The quadriplegia treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Quadriplegia Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The quadriplegia treatment market size has grown strongly in recent years. It will grow from $1.78 billion in 2023 to $1.92 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to improved surgical techniques, the introduction of drugs like corticosteroids, advances in stem cell therapy and regenerative medicine, the development of specialized rehabilitation programs, increased awareness and advocacy efforts by organizations, and patient groups.
The quadriplegia treatment market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the expansion and modernization of healthcare facilities, increased funding for research and development in spinal cord injury treatments, the growing availability and adoption of advanced wheelchairs, exoskeletons, and other mobility aids, integration of telehealth and remote monitoring, the adoption of telehealth services. Major trends in the forecast period include advanced exoskeletons, robotic rehabilitation systems, expansion of telehealth platforms providing remote consultations, utilization of AI and machine learning algorithms to predict complications, and advances in 3D printing to create customized orthotic and prosthetic devices.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/quadriplegia-treatment-global-market-report
Scope Of Quadriplegia Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Quadriplegia Treatment Market Overview
Market Drivers –
An increase in the incidence of spinal cord injuries is expected to propel the growth of the quadriplegia treatment market going forward. Spinal cord injuries (SCIs) are damage to the spinal cord resulting from trauma or disease, leading to loss of function such as mobility or sensation below the injury site. The incidence of spinal cord injuries is increasing due to factors such as higher rates of motor vehicle accidents, falls, sports injuries, and violence. Quadriplegia treatment for spinal cord injuries focuses on maximizing functional independence and quality of life through rehabilitation, assistive technologies, and medical management. For instance, in October 2022, according to the New Zealand Spinal Trust report, a New Zealand-based non-profit organization, the number of sporting and leisure spinal cord injuries (SCI) in New Zealand increased from 14% in 2020 to 19% in 2021. Wheeled non-motorsports (such as mountain biking and cycling) accounted for 25% of these injuries, followed by water-related accidents (18%) and horse-related accidents (14%). Therefore, an increase in the incidence of spinal cord injuries is driving the growth of the quadriplegia treatment market.
Market Trends –
Major companies operating in the quadriplegia treatment market are developing new products, such as wireless tongue-controlled interfaces, to improve mobility and independence for patients. Wireless tongue-controlled interfaces in quadriplegia treatment enable individuals to operate devices or communicate through tongue movements, enhancing their independence and quality of life. For instance, in April 2023, Media Lab spinoff Augmental, a US-based provider of digital devices and interfaces, launched MouthPad, a tongue-controlled interface that enables users to interact with digital devices hands-free. This innovative device is designed to be a game-changer for people with limited hand-motor control as well as for anyone looking to interact with computers in a more natural and expressive way. It uses a custom-fit, 3D-printed mouthpiece with a trackpad chip that detects tongue movements and pressure. This allows users to control their devices by sweeping their tongue across the trackpad, with tongue presses for left clicks and sip gestures for right clicks.
The quadriplegia treatment market covered in this report is segmented –
1) By Treatment Type: Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics And Muscle Relaxants, Antibiotics
2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
3) By Distribution Channel: Online Stores, Drug Stores, Retail Pharmacies, Hospital Pharmacies
Get an inside scoop of the quadriplegia treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16521&type=smp
Regional Insights –
North America was the largest region in the quadriplegia treatment market in 2023. The regions covered in the quadriplegia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the quadriplegia treatment market are <b>Johnson & Johnson Services Inc., Merck & Co., Sanofi S.A., Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Roche Holdings Inc., Takeda Pharmaceutical Co Ltd, Medtronic plc, Eli Lily & Co., Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceuticals Industries Ltd., Baxter International, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Limited, Cipla Ltd, Ottobock SE & Co. KGaA, Zydus Lifesciences Ltd., Invacare Corporation, Sunrise Medical Company Private Limited, Pride Mobility Products Corp.</b>
Table of Contents
1. Executive Summary
2. Quadriplegia Treatment Market Characteristics
3. Quadriplegia Treatment Market Trends And Strategies
4. Quadriplegia Treatment Market – Macro Economic Scenario
5. Global Quadriplegia Treatment Market Size and Growth
…
32. Global Quadriplegia Treatment Market Competitive Benchmarking
33. Global Quadriplegia Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Quadriplegia Treatment Market
35. Quadriplegia Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
